The best injection sites for Mounjaro and how site choice affects side effects

Rotate every dose. Using the same spot repeatedly can cause lipohypertrophy, a build-up of fatty tissue under the skin that slows or unpredictably changes how tirzepatide is absorbed.
Stomach discomfort is not caused by injection site. Nausea, vomiting and digestive upset come from how tirzepatide works systemically, not from where the pen touches your skin, site choice won't eliminate GI effects, but keeping the pen away from the waistband can reduce local bruising.
Injection-site reactions are common and usually mild. The NHS notes that redness, itching or swelling at the site are among the most commonly reported reactions; they are generally short-lived.
Serious side effects require medical attention. Severe, persistent stomach pain that spreads to the back, signs of an allergic reaction, or symptoms of pancreatitis need urgent assessment, not a wait-and-see approach.

For fewer side effects with Mounjaro, inject into the abdomen, thigh, or upper arm and rotate between them weekly. Rotating sites prevents localised skin reactions — redness, lumps, or soreness — and helps absorption stay consistent, which matters for both tolerability and how well the medicine works. Mounjaro (tirzepatide) is a prescription-only medicine; a clinician decides whether it is right for you and guides your injection technique as part of that care. Our prescribers at nume discuss injection sites, technique and side effects at every consultation.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Step-by-step: choosing your site, rotating correctly, and spotting problems early

Step 1, pick one of the three licensed sites and understand why they differ

The Mounjaro SmPC lists three subcutaneous injection sites: the abdomen (at least 5 cm from the navel), the front or outer thigh, and the upper arm. All three are clinically suitable. The abdomen is easiest to self-inject because the skin is generally easier to pinch; the thigh works well and is a reliable alternative; the upper arm is harder to reach alone, though a carer or partner can help. The NHS tirzepatide information page and the medicine's Patient Information Leaflet both confirm these three locations, the leaflet should be your reference for specific measurements and diagrams.

One misconception worth clearing up: many people starting Mounjaro assume that injecting into the abdomen will make nausea worse because it is near the stomach. It won't. Nausea comes from tirzepatide's effect on gut-hormone receptors throughout the body, not from where the subcutaneous needle sits. Site choice simply won't move the GI effects around.

What site choice does influence is local comfort and absorption consistency. The abdomen tends to absorb a little faster; the thigh slightly slower. For most people this difference is not clinically meaningful at stable doses, but if you want to choose where to inject Mounjaro to keep side effects as manageable as possible, sticking to one site exclusively can cause tissue changes over time that make absorption erratic. See our full guide to Mounjaro injection technique for step-by-step practical detail.

Step 2, build a rotation plan that you can actually remember

Rotation means choosing a different spot within and across the three sites each week. A simple approach: divide the abdomen into a clock face and move one position clockwise each dose; alternate thighs week to week; bring in the upper arm occasionally if a partner can assist. The goal is to give each area at least two to three weeks of rest before returning to it.

Consistent rotation reduces the risk of lipohypertrophy, firm, painless fatty lumps under the skin that can form when the same millimetre of tissue is repeatedly punctured. Injecting into a lump means the medicine absorbs poorly and unpredictably, which can affect both results and tolerability. If you notice an area that feels harder than surrounding tissue, avoid it and let it recover; mention it to your prescriber.

Our dedicated guide to the best injection sites has a printable rotation tracker and explains how to feel for skin changes before each dose. If you are still weighing up your options, our page on finding the best place for your Mounjaro injection walks through the practical pros and cons of each site. Changing the needle with every injection also helps: a blunt or barbed needle makes skin trauma worse, which increases local soreness. Fresh needles for every dose are a small habit with a noticeable difference in comfort.

Step 3, prepare the site and the pen correctly each time

Temperature is the step most people skip. A Mounjaro pen taken straight from the fridge and injected immediately is colder than body temperature; cold injections sting more and can cause more localised irritation. Let the pen sit at room temperature for around 30 minutes before use, the exact storage window and warming guidance are in the Patient Information Leaflet and on the Mounjaro SmPC, available on the electronic Medicines Compendium. Never warm the pen in hot water or a microwave.

Clean the chosen skin area with an alcohol swab and allow it to dry fully before injecting, wet skin stings and increases the chance of a minor site reaction. Pinch the skin gently, insert at the angle shown in the leaflet, and inject slowly. Hold the pen in place for the full count after injection to avoid leakage. Then release. There is no need to rub the site afterwards; gentle pressure with a clean finger is enough if there is mild bleeding. For storage details between doses, our Mounjaro storage guide covers the temperature requirements and travel rules.

When to get medical help (and how to report a problem

Most injection-site reactions) transient redness, slight swelling, brief itching, settle on their own. They are among the most commonly recorded effects in clinical trial data. If a reaction is spreading beyond the injection site, is warm to touch, or looks infected after 48 hours, contact your GP or call NHS 111.

Separately, some side effects of tirzepatide are unrelated to site and need prompt attention. The MHRA updated its guidance on GLP-1 medicines in January 2026 to highlight acute pancreatitis: severe, persistent abdominal pain that radiates to the back, with or without vomiting, warrants urgent medical review. Do not inject the next dose until a clinician has assessed you. Other symptoms that need the same urgency: signs of a serious allergic reaction (throat tightening, difficulty breathing, rapid swelling of the face or lips), significant dehydration from prolonged vomiting, or new vision changes. Our Mounjaro injection side effects page covers the full picture.

Suspected side effects can be reported directly to the MHRA through the Yellow Card scheme, patients can do this themselves, not just prescribers. If you have questions about a specific reaction you have experienced, our team is available seven days a week; reach us via the contact page.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions